EastGate Biotech (ETBI) announced that it signed a non-dilutive licensing deal with a European consortium of several medium sized drug makers that gives them rights to market the oral insulin mouth rinse to the European market. The consortium will have a 15 year exclusive license with a 10% royalty payable to ETBI. Nico Innovagroup mentioned […]
EmailWire Instagram
This error message is only visible to WordPress admins
Error: No connected account.
Please go to the Instagram Feed settings page to connect an account.